Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study

<p>Background: We have previously shown that increased resting-state functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) within the frontal resting-state networks in Alzheimer's disease (AD) patients reflects residual, possibly compensatory, function. This sugg...

Descrizione completa

Dettagli Bibliografici
Autori principali: Griffanti, L, Wilcock, G, Voets, N, Bonifacio, G, Mackay, C, Jenkinson, M, Zamboni, G
Natura: Journal article
Pubblicazione: Karger Publishers Open Access 2016
_version_ 1826302610126143488
author Griffanti, L
Wilcock, G
Voets, N
Bonifacio, G
Mackay, C
Jenkinson, M
Zamboni, G
author_facet Griffanti, L
Wilcock, G
Voets, N
Bonifacio, G
Mackay, C
Jenkinson, M
Zamboni, G
author_sort Griffanti, L
collection OXFORD
description <p>Background: We have previously shown that increased resting-state functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) within the frontal resting-state networks in Alzheimer's disease (AD) patients reflects residual, possibly compensatory, function. This suggests that symptomatic treatments should aim to enhance FC specifically in these networks.</p><p> Methods: 18 patients with probable AD underwent brain MRI and neuropsychological assessment at baseline and after 12 weeks of treatment with donepezil. We tested if changes in cognitive performance after treatment correlated with changes in FC in resting-state networks known to be altered in AD.</p><p> Results: We found increases in FC in the orbitofrontal network that correlated with cognitive improvement after treatment. The increased FC was greatest in patients who responded most to treatment.</p><p> Conclusion: This ‘proof of concept' study suggests that changes in network-specific FC might be a biomarker of pharmacological intervention efficacy in AD.</p>
first_indexed 2024-03-07T05:50:11Z
format Journal article
id oxford-uuid:e89a0157-79ca-4df5-9ef3-eaa716a8f20a
institution University of Oxford
last_indexed 2024-03-07T05:50:11Z
publishDate 2016
publisher Karger Publishers Open Access
record_format dspace
spelling oxford-uuid:e89a0157-79ca-4df5-9ef3-eaa716a8f20a2022-03-27T10:48:02ZDonepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e89a0157-79ca-4df5-9ef3-eaa716a8f20aSymplectic Elements at OxfordKarger Publishers Open Access2016Griffanti, LWilcock, GVoets, NBonifacio, GMackay, CJenkinson, MZamboni, G<p>Background: We have previously shown that increased resting-state functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) within the frontal resting-state networks in Alzheimer's disease (AD) patients reflects residual, possibly compensatory, function. This suggests that symptomatic treatments should aim to enhance FC specifically in these networks.</p><p> Methods: 18 patients with probable AD underwent brain MRI and neuropsychological assessment at baseline and after 12 weeks of treatment with donepezil. We tested if changes in cognitive performance after treatment correlated with changes in FC in resting-state networks known to be altered in AD.</p><p> Results: We found increases in FC in the orbitofrontal network that correlated with cognitive improvement after treatment. The increased FC was greatest in patients who responded most to treatment.</p><p> Conclusion: This ‘proof of concept' study suggests that changes in network-specific FC might be a biomarker of pharmacological intervention efficacy in AD.</p>
spellingShingle Griffanti, L
Wilcock, G
Voets, N
Bonifacio, G
Mackay, C
Jenkinson, M
Zamboni, G
Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
title Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
title_full Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
title_fullStr Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
title_full_unstemmed Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
title_short Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
title_sort donepezil enhances frontal functional connectivity in alzheimer s disease a pilot study
work_keys_str_mv AT griffantil donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy
AT wilcockg donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy
AT voetsn donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy
AT bonifaciog donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy
AT mackayc donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy
AT jenkinsonm donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy
AT zambonig donepezilenhancesfrontalfunctionalconnectivityinalzheimersdiseaseapilotstudy